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Norepinephrine (NE) is thought to mediate its effects through G-protein coupled receptors. 
However, previous studies have shown that NE and another primary amine, serotonin, also have 
the ability to exert effects in a receptor-independent manner. We hypothesized that the enzyme 
transglutaminase II (TG II) has the ability to modify proteins with NE and that this modification 
is physiologically relevant. As our model we used rat aortic and vena cava tissues, two tissues 
that depend on NE to modulate vascular tone. Immunohistochemical and immunocytochemical 
staining showed that NE and TG II are present in smooth muscle cells of these tissues. Western 
analysis shows aorta and vena cava homogenate proteins are recognized by an antibody 
raised against NE conjugated to bovine serum albumin (NE-BSA). NE and α-actin colocalize 
in cultured aorta and vena cava smooth muscle cells. Freshly dissociated smooth muscle 
cells from these vessels were able to take up NE-biotin. In isolated tissue baths, inhibition of 
TG II with cystamine (0.5 mM) completely abolished NE-induced contraction in the aorta but 
only attenuated the receptor-independent contractant KCl (max contraction to 100 mM KCl in 
cystamine treated = 88.8 ± 7.0% of vehicle treated, p < 0.05). In the vena cava, contraction to 
NE was abolished with 0.1 mM cystamine and KCl contraction was attenuated (max contraction 
to 100 mM KCl in cystamine treated = 54.8 ± 7.0% of vehicle treated, p < 0.05). Taken together, 
these results show that vascular smooth muscle cells take up and utilize NE for the modification 
of proteins, and that this modification may play an important role in vascular contraction.
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bond (Figure 1). This reaction is catalyzed by the enzyme trans-
glutaminase II (TG II), an enzyme that also covalently links proteins 
through a ε-(γ-glutamyl)lysine bond. This modification was first 
shown to occur within the platelet, where small GTPases become 
serotonylated, constitutively activating them and leading to the 
internalization of the serotonin reuptake transporter (Walther 
et al., 2003). Subsequently, serotonylation of proteins has been 
shown to occur on the small GTPases Rab3a and Rab27a in the 
pancreatic beta cell, rendering them constitutively active and facili-
tating insulin secretion (Paulmann et al., 2009). Serotonylation also 
occurs to proteins of vascular smooth muscle cells, where it has 
been shown to accelerate RhoA degradation (Guilluy et al., 2007) 
and modify aortic contraction (Watts et al., 2009).
We hypothesized that TG II utilizes the primary amine NE as a 
substrate for protein modification (Figure 1) and that this modi-
fication has physiological significance in the vasculature. As our 
model, we chose aortic and vena cava tissues from the rat, two tis-
sues in which depend on NE via the sympathetic nervous system 
to control vascular tone. In order to follow the addition of NE to 
proteins, we utilized a biotin-conjugated NE (NE-biotin) in several 
of our experiments.
Materials and Methods
aniMal Use
Male Sprague–Dawley rats (Charles River Laboratories, Inc., 
Portage, MI, USA) were used. Rats were anesthetized with pento-
barbital (60 mg kg−1, i.p.) prior to removal of tissues. Procedures 
introdUction
Norepinephrine (NE), a member of the class of primary amines known 
as catecholamines, has a number of different roles throughout the 
body. One of these functions is as a mediator of vascular tone through 
its actions as a neurotransmitter of the sympathetic nervous system. 
The physiological responses of NE have been attributed to its actions 
on adrenergic receptors, a class of G-protein coupled receptors that are 
the primary targets for the two catecholamines NE and epinephrine. 
Adrenergic receptors were first divided into two main groups based on 
their excitatory (α-adrenergic receptors) or inhibitory (β-adrenergic 
receptors) effects in the vasculature (Ahlquist, 1948). The vasocon-
strictive effects of the catecholamines NE and epinephrine are medi-
ated through their interactions with α-adrenergic receptors, while 
their vasodilatory effects are mediated through their interactions with 
β-adrenergic receptors (Ahlquist, 1948).
While many of the effects of primary amines are mediated 
through their receptors, there have been reports where their effects 
cannot be explained by receptor activation. This includes the inabil-
ity of adrenergic and serotonergic antagonists to block NE- and 
serotonin-induced reduction of endothelial cell barrier function 
(Bottaro et al., 1986). In addition to this, serotonin receptor antago-
nists do not affect serotonin-induced proliferation (Guilluy et al., 
2009) and hypertrophy (Lee et al., 1994; Eddahibi et al., 2001) of 
bovine pulmonary smooth muscle cells.
Recently, a novel, receptor-independent mode for signal trans-
duction of amines has been described. Serotonylation is the cova-
lent linkage of serotonin to a protein through a glutamyl-amide 
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cell cUltUre
Aortic and vena cava smooth muscle cells were derived from explants 
of the thoracic aorta or vena cava. Cells were fed with DMEM sup-
plemented with 10% fetal bovine serum and 1% penicillin/strepto-
myocin. Cells were plated to cover slips for immunocytochemical 
experiments. Aortic cells used were between passages 2 and 6; vena 
cava cells used were from passages 2 or 3. All explants stained posi-
tive for α-actin, smooth muscle cell specific (1:1000; mouse mono-
clonal, FITC conjugate, F3777, Sigma, St. Louis, MO, USA).
iMMUnocytocheMistry
For experiments using NE-biotin, cells were equilibrated in physi-
ological salt solution (PSS: 103 mM NaCl; 4.7 mM KCl; 1.13 mM 
KH
2
PO
4
; 1.17 mM MgSO
4
-7H
2
0; 1.6 mM CaCl
2
-2H
2
O; 14.9 mM 
NaHCO
3
; 5.5 mM dextrose and 0.03 mM CaNa
2
 EDTA) plus the 
monoamine oxidase inhibitor pargyline (10 μM) for 30 min and 
then incubated with either NE-biotin (12.7 μM, IBL, Hamburg, 
Germany) or vehicle (N,N-dimethylformamide) for 1 h. When ana-
lyzed by NMR, NE-biotin was found to be a mixture of species, 
with the biotin attached to the primary amine and hydroxyl groups. 
The ratio of these species was unable to be determined. Thus, the 
were performed in accordance of Michigan State University 
with the approval of the Institutional Animal Use and Care 
Committee.
iMMUnohistocheMistry
Paraffin-embedded tissue sections were dewaxed, unmasked and 
treated as previously described (Ni et al., 2008). Primary antibodies 
used were: anti-TG II (1:1000; mouse monoclonal TG100, LabVision, 
Fremont CA, USA) and anti-NE-bovine serum albumin (NE-BSA) 
(1:500; rabbit polyclonal, ab8887, Abcam, Cambridge, MA, USA). 
Primary antibodies were left out of some experiments and tissues 
were developed in the presence of only secondary antibody.
dissociation of vascUlar sMooth MUscle cells
Thoracic aorta and vena cava tissues were isolated, dissected and 
cleaned as previously described (Thakali et al., 2008). Cells were resus-
pended in Dulbecco’s phosphate buffered saline (DPBS; 2.57 mM 
KCl, 1.47 mM KH
2
PO
4
, 137.93 mM NaCl, 8.06 mM Na
2
HPO
4
-7H
2
O, 
pH 7.2) plus sodium nitroprusside (872 nM). Cells were made to 
adhere to poly-lysine (50 μg/mL) coated coverslips using the Shandon 
Cytospin 4 Centrifuge (Thermo Scientific, Waltham, MA, USA).
Figure 1 | Depiction of Tg ii catalyzed reactions. Top reaction depicts protein cross-linking reaction of TG II. The middle reaction depicts the addition of serotonin 
to proteins, a modification known as serotonylation. Bottom reaction depicts our hypothesized modification, the covalent linkage of NE to proteins.
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TG II blot. The blot probed with the anti-NE-BSA antibody was 
blocked using Odyssey blocking buffer (Li-Cor Biosciences, Lincoln, 
NE, USA) and was analyzed using the Odyssey infrared imaging 
system (Li-Cor Biosciences, Lincoln, NE, USA). The blot probed 
with the anti-TG II antibody was blocked in 4% w/v chick egg 
ovalbumin and placed in ECL (Amersham Life Sciences, Arlington 
Heights, IL, USA) prior to exposure to film. The film was scanned 
and placed within the figure without modification using Adobe 
Photoshop. Densitometric analysis was done using ImageJ.
isoMetric contraction
Endothelial cell-intact rings of aorta and vena cava tissues were 
hung in tissue baths for isometric tension recordings using Grass 
transducers and PowerLab data Acquisitions (Colorado Springs, 
CO, USA). Rings were pulled to optimum resting tension (4000 mg 
aorta, 1000 mg vena cava), and equilibrated for 1 h, with washing, 
prior to exposure to compounds. Tissue baths contained 37°C, aer-
ated (95% O
2
/CO
2
) PSS. To test viability, aortic rings were treated 
with an initial concentration of 10 μM phenylephrine (PE), an 
α
1
-adrenergic receptor agonist. Since the vena cava does not con-
tract to PE, vena cava rings were treated with an initial concen-
tration of 10 μM NE. All tissues had an intact endothelial layer, 
evidenced by a robust (>50%) relaxation to acetylcholine (1 μM) 
in tissues contracted to half-maximum with PE (aorta) or con-
tracted to 10 μM PGF
2α (vena cava). Tissues were incubated with 
vehicle (water) or the TG II inhibitor cystamine (0.01–0.1 mM) 
for 30–60 min prior to cumulative addition of NE (10−9−10−5 M). 
Tissues were then washed, incubated in the same concentration of 
cystamine or vehicle for 30–60 min prior to the cumulative addi-
tion of the non-receptor mediated contractant potassium chloride 
(KCl, 6–100 mM). Data are reported as a percentage of the initial 
contraction to PE (aorta) or NE (vena cava).
resUlts
tG ii and ne are present in sMooth MUscle cells froM aorta 
and vena cava tissUes
Immunohistochemical staining of NE in rat aortic and vena cava 
tissues shows positive staining in all layers of these two tissues 
(Figure 2A). TG II staining, in contrast, appears to be localized 
to the smooth muscle layers of the media in both aortic and vena 
cava tissues (Figure 2B). Immunocytochemical staining of freshly 
dissociated smooth muscle cells, cells that mediate vascular con-
traction, confirmed TG II was present in this cell type for both the 
aorta (Figure 2C, left) and the vena cava (Figure 2C, right), as was 
NE (Figure 2D, aorta left, vena cava right). In the vena cava, cell 
types besides smooth muscle cells also stained for NE (Figure 2D, 
right). For both aortic and venous smooth muscle cells, the image 
overlays show colocalization of α-actin with TG II (Figure 2C) 
and NE (Figure 2D).
ne is attached to proteins of the vascUlatUre
Western analysis of aorta and vena cava homogenates showed 
protein bands that were recognized by an antibody raised against 
NE-BSA (Figure 3A). Because this antibody was made against NE 
that had been conjugated to a protein, it will preferentially bind 
to proteins that have been covalently modified by NE. Because 
these proteins were from tissues not exposed to exogenous NE 
concentration of NE-biotin used is the maximum possible. This 
is reasonable, as NE-biotin was used to track the location of NE 
qualitatively, and not quantitatively. Freshly dissociated smooth 
muscle cells were then rinsed in PBS and fixed in Zamboni’s fixative 
for 20 min, followed by permeabilization by incubating in 0.1% 
Trition X-100 for 20 min. Cultured smooth muscle cells were rinsed 
and then fixed with acetone for 1 min. Cells not used in NE-biotin 
experiments were immediately fixed. Primary antibodies used were 
anti-NE-BSA (1:500; rabbit polyclonal, ab8887, Abcam, Cambridge, 
MA, USA), anti-TG II (1:1000; rabbit polyclonal, ab421, Abcam, 
Cambridge, MA, USA), and anti-α-actin (1:1000; mouse mono-
clonal, FITC conjugate, F3777, Sigma, St. Louis, MO, USA) in PBS. 
Secondary antibodies used were Cy3-conjugated Affini Pure goat 
anti-rabbit (1:1000; IgG, Jackson ImmunoResearch Laboratories 
Inc., West Grove, PA, USA) and Rhodamine Red-X-conjugated 
Streptavidin (1:1000; Jackson ImmunoResearch Laboratories 
Inc., West Grove, PA, USA). After incubation in secondary, cover 
slips were blotted dry and mounted on slides using Prolong Gold 
medium with DAPI (Invitrogen, Carlsbad, CA, USA). Slides were 
viewed and photographed on a Nikon Eclipse Ti-S microscope 
using NIS Elements BR 3.00 software. The light source was a Nikon 
intensilight C-HGFI, and the camera a Nikon Digital Sight DS-Qi1. 
Slides were viewed under a 60× Nikon Plan Apo oil-immersion 
objective using non-drying immersion oil, type A. Three Nikon 
filters were used: UV-2EC 96310 (lot number: C109990), HYQ 
TRITC 96321 (lot number: C112237) and HYQ FITC 96320 (lot 
number: C111294). Excitation ranges were: UV-2EC 340-380 nm, 
HYQ TRITC 528-552 nm, and HYQ FITC 450-490 nm. Emission 
ranges were: UV-2EC 435–485, HYQ TRITC 580–632, and HYQ 
FITC 515–555. Images were unaltered when combined into the 
overlay image. Analysis of the images was done in ImageJ (Rasband, 
1997–2009), using the JACoP plugin (Bolte and Cordelieres, 2006) 
to find Van Steensel’s cross-correlation functions (CCF) with a pixel 
shift of δ = ± 20. Van Steensel’s CCFs are formed by shifting the 
image in one channel in the x-direction pixel by pixel relative to 
the second channel and calculating a Pearson’s coefficient for each 
shift. The Pearson’s coefficients are then plotted as the function of 
pixel shifts (δx). Colocalization events are indicated by a peak at 
δ = 0, while partial colocalization will shift the peak slightly to the 
left or right. Noise and differing intensities between the two chan-
nels will reduce the maximum peak of the CCF from one and also 
increase the width of the peak at half maximum.
Western analysis
Protein isolation and western blotting procedures were performed 
as previously described using standard SDS-PAGE conditions 
and transferring proteins to either nitrocellulose (for TG II) or 
PVDF-FL (for NE) membranes (Ni et al., 2008). Primary anti-
bodies used were anti-NE-BSA (1:500; rabbit polyclonal, ab8887, 
Abcam, Cambridge, MA, USA), anti-TG II (1:1000; mouse mon-
oclonal TG100, LabVision, Fremont, CA, USA) and anti-β-actin 
(1:1000; mouse monoclonal, A2228, Sigma, St. Louis, MO, USA). 
Secondaries used were IR dye 680 donkey anti-mouse (1:1000; 
Li-Cor Biosciences, Lincoln, NE, USA) and IR dye 800 goat anti-
Rabbit (1:1000; Li-Cor Biosciences, Lincoln, NE, USA) for the blot 
probed with anti-NE-BSA antibody, and sheep peroxidase-linked 
anti-mouse (1:2000; GE Healthcare, Piscataway, NJ, USA) for the 
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of Figure 3B: aorta = 0.666 at δ = -1, vena cava = 0.805 at δ = 0). The 
CCF peak at zero in the vena cava explant indicates complete colo-
calization, while the CCF peak slightly aside from zero (at δ = −1) 
in the aortic explants is indicative of partial colocalization. The 
reduction of peaks from a CCF = 1 may indicate either noise in the 
channels, different intensities between the two channels, or both. 
However, it is still possible to identify a colocalization event.
ne-biotin is taken Up by vascUlar cells
To differentiate between NE that was already present, taken up or 
made inside the cell and to confirm that exogenous NE could be 
taken up, cells were treated with NE-biotin (12.7 μM) for 30 min. 
Immunocytochemical staining with Rhodamine-Red-X-conjugated 
streptavidin showed NE-biotin was taken up by smooth muscle cells 
of the aorta (Figure 4, left) and, in the vena cava, by smooth muscle 
cells as well as by other non-identified vascular cells (Figure 4, 
after being removed from the animal, they reflect a physiological 
state of protein amidation, supporting our hypothesis that proteins 
are naturally amidated by NE. β-actin was probed for to ensure 
equal loading of protein. Using ImageJ, densitometric analysis of 
the blot shows the differences between aorta and vena cava band 
intensities (Figure 3B). Values for band intensities were normal-
ized to β-actin.
Because freshly dissociated cells tended to be compacted 
(Figure 2D), cultured aortic and vena cava smooth muscle cells 
were used next to better determine subcellular localization of NE. 
Immunocytochemical staining with the anti-NE-BSA antibody 
showed that endogenous NE colocalized with α-actin fibers in 
cultured smooth muscle cells from aorta (Figure 3C, left) and vena 
cava (Figure 3C, right) tissues. Analysis of these images using Van 
Steensel’s CCF points toward colocalization of NE with α-actin 
(Figure 3D; peaks of Van Steensel cross-correlation function peaks 
Figure 2 | Tg ii and Ne are present in aorta and vena cava tissues. (A) 
Immunohistochemical staining of NE in a rat aorta (left) and vena cava (right). 
L = lumen. Arrows point to areas of staining. (B) Immunohistochemical staining 
of TG II in the rat aorta (left) and vena cava (right). (C) Immunocytochemical 
staining of TG II (red) in freshly dissociated smooth muscle cells of the aorta (left) 
and vena cava (right). Smooth muscle cells were identified with a smooth 
muscle cell-specific α-actin antibody (green). Nuclei (blue) were identified using 
4’,6-diamidino-2-phenylindole (DAPI). (D) Immunocytochemical staining of NE 
(red) in freshly dissociated smooth muscle cells of the aorta (left) and vena cava 
(right). Images are representative of tissues taken from four to five different rats.
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difference cannot be explained by the amount of TG II present 
in each of the tissues, as the TG II protein content of aorta and 
vena cava homogenates did not differ significantly (Figure 5F). In 
contrast to NE-induced contraction, KCl-induced contraction, a 
receptor-independent contraction, was only modestly reduced by 
concentrations of cystamine that abolished NE-induced contrac-
tion in both the aorta (Figure 5C; max contraction to 100 mM 
KCl in 0.5 mM cystamine treated = 88.8 ± 7.5% of vehicle treated) 
and the vena cava (Figure 5D; max contraction to 100 mM KCl in 
0.1 mM cystamine treated = 54.8 ± 21.2% of vehicle treated).
discUssion
The importance of NE in vascular physiology is well established. 
Both arteries and veins are innervated by the sympathetic nerv-
ous system, and NE is critical for maintaining vascular tone. The 
current model of NE action is dependent on its interaction with 
right). This is consistent with endogenous NE staining in both vessel 
types (Figure 2D). Once taken up, NE-biotin was largely cytosolic. 
The overlays show colocalization of α-actin with NE-biotin, which 
suggests that NE-biotin is being covalently attached to α-actin.
inhibition of transGlUtaMinase ii activity abolishes ne-
indUced contraction
The physiological importance of NE-amidation of proteins is illus-
trated by the abolishment of NE-induced contraction in the presence 
of cystamine, a TG II inhibitor. Cystamine abolished NE-induced 
contraction in a concentration-dependent manner in both the aorta 
(Figure 5A) and vena cava (Figure 5B). Vena cava tissues proved 
to be more sensitive to cystamine inhibition, as concentrations of 
cystamine (0.1 mM) that merely attenuated NE-induced contrac-
tion in the aorta (max contraction to NE = 67.6 ± 3.9 % of vehicle) 
completely abolished contraction in the vena cava (Figure 5E). This 
Figure 3 | Proteins amidated by endogenous Ne. (A) Western analysis showing 
proteins recognized by an anti-NE-BSA antibody in rat aorta and vena cava 
homogenates not exposed to exogenous NE. (B) Densitometry of the five darkest 
bands, (arrows in A) from the Western analysis. Each band was normalized to β-actin. 
(C) Images of cultured smooth muscle cells from rat aorta (left) and vena cava (right). 
Cells were stained for nuclei (DAPI, blue, top left), α-actin (green, top right) and NE 
(red. bottom left). Overlay of the three images is bottom right. Colocalization is 
indicated by the yellow color. Arrows point to areas of colocalization. Images are 
representative of cells cultured from four different rats. (D) Van Steensel’s 
cross-correlation functions of α-actin and NE overlays. Peaks at or near δ = 0 indicate 
a colocalization event. Graphs were made using the images above them, and are 
representative of graphs made of images from the cells of four different rats.
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Figure 4 | Aorta and vena cava tissues can take up and attach Ne-biotin to 
proteins. Freshly dissociated smooth muscle cells of the aorta (left) and vena 
cava (right) were incubated with either 12.7 μM NE-biotin or vehicle (not shown) 
for 30 min. Staining with a Rhodamine-Red-X conjugated streptavidin (red, 
bottom left) showed that NE-biotin entered the smooth muscle cells (indicated 
by α-actin staining, green, top right), and, in the vena cava, other vascular cells 
(red staining, bottom right of the vena cava). Nuclei are indicated by DAPI 
staining. Images are representative of tissues from four different rats.
Figure 5 | inhibition of Tg ii abolishes contraction to Ne in aortic and 
vena cava tissues. (A–D) Effect of vehicle (open symbol) and cystamine 
(0.01–1 mM) on contraction in the vena cava and aorta. NE-induced 
contraction was eventually abolished in the aorta (A) and vena cava (B). 
Contraction to KCI was attenuated, but not abolished in both the aorta (C) and 
vena cava (D). Cys = Cystamine * indicates statistical difference (p <0.05) 
from vehicle-treated values. Points and vertical lines represent means ± SEM 
for the number of animals in parentheses. (e) NE-induced vena cava 
contraction was more sensitive than aortic contraction to TG II inhibition. (F) 
Densitometry of a Western analysis demonstrating the presence of TG II 
(70 kDa) in rat aorta and vena cava homogenates. TG II was normalized 
to β-actin.
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an  adrenergic receptor. However, other primary amines, such as 
serotonin, elicit biological effects that are independent of receptor 
binding (Eddahibi et al., 2001; Guilluy et al., 2009). Since TG II can 
recognize and utilize serotonin as a substrate, other primary amines 
such as NE can also be candidates for TG II-mediated amidation 
events. The present work suggests that this is indeed the case, and 
presents a novel mechanism through which NE elicits a biologi-
cal response in the vasculature. The importance of this work is 
exemplified in the alteration of sympathetic nervous system activ-
ity in several models of hypertension (Luo et al., 2003; King et al., 
2008), and in that sympathetic nervous system activity is commonly 
increased in human essential hypertension (Guyenet, 2006).
tG ii and sMooth MUscle cells
Other studies have shown that TG II is present in the aortic smooth 
muscle cells (Lai et al., 2007) and the present work confirms this. 
Our study shows that TGII is also present in venous smooth muscle 
cells (Figure 2C), which is a novel finding. Immunohistochemical 
staining showed that NE was present in virtually all layers of both 
the aorta and vena cava (Figure 2A). TG II, on the other hand, was 
primarily localized to the smooth muscle layers of these tissues 
(Figure 2B). Immunocytochemical staining confirmed that NE 
and TG II both exist in smooth muscle cells of the vasculature, 
and that NE was present in additional, unidentified cell types 
(Figures 2C,D), that probably correspond to the non-smooth 
muscle cell layers of aorta and vena cava that stained positive 
for NE in Figure 2A. This puts the tools for protein amidation 
to NE together in vascular smooth cells, making these cells likely 
candidates in which this process can occur. The possibility of 
smooth muscle cells to take up NE was demonstrated in their 
ability to incorporate NE-biotin into the cell when incubated 
with it (Figure 4).
Although staining of NE was observed in freshly dissociated 
smooth muscle cells, its exact cellular localization was difficult to 
visualize due to the compacted nature of these cells. To overcome 
this, cultured smooth muscle cells, which are more diffuse, were 
used. Immunocytochemical staining showed that while NE existed 
throughout the cell, it had a high correlation with α-actin fibers 
(Figure 3C). Colocalization was assessed using the JACoP plugin 
in ImageJ. Van Steensel’s cross-correlation function showed a peak 
near or at zero, suggesting a colocalization event had occurred. This 
was similar to what we had reported earlier with serotonin (Watts 
et al., 2009). NE’s colocalization with α-actin fibers is significant 
because isometric contraction of vascular smooth muscle cells is 
an α-actin dependent process (Ogden et al., 2006).
physioloGical relevance
To show that protein amidation to NE is physiologically rel-
evant, it is necessary for protein amidation to occur naturally 
and modify biological activity. Protein bands of rat aorta and 
vena cava homogenates not exposed to either the monoamine 
oxidase inhibitor pargyline or exogenous NE were recognized 
by an antibody raised against NE, suggesting NE amidation to 
proteins naturally occurs (Figure 3A). Biological function of this 
process was assayed by measuring isometric contraction to NE 
in the presence and absence of cystamine, which inhibits TG II 
by acting as a competitive substrate (Figures 5A,B). NE-induced 
contraction was abolished by cystamine while contraction to the 
receptor-independent contractile agent KCl was only slightly 
reduced (Figures 5C,D). KCl-induced contraction was impor-
tant in showing that the tissues were viable at the concentra-
tion of cystamine used. KCl-treatment stimulates contraction 
by depolarizing the cell, resulting in Ca2+ influx through l-type 
calcium channels. Our data suggest that TG II function is critical 
for vascular contraction to NE; this may be through its ability to 
covalently attach NE to proteins. While it is possible that TG II 
is playing a more global role in influencing vascular contraction 
given that cystamine reduced KCl-induced contraction at higher 
concentrations, it should be noted that part of the KCl-induced 
contraction may be due to the NE that is present in sympathetic 
nerve terminals that are intrinsically a part of the isolated vessels. 
When KCl is added, these cells would also depolarize, resulting 
in the release of NE which then can be taken up and used as a 
substrate for TG II by the smooth muscle cells.
Another way that TG II is capable of influencing contraction is 
through its ability to act as a G protein, denoted as G
h
 (Griffin et al., 
2002). This is especially likely with NE, as G
h
 couples to both the α
1B
 
and α
1D
 -adrenergic receptors (Chen et al., 1996), two receptors that 
play a significant role in vascular contraction (David et al., 2010). 
This could also partially explain why NE-induced contraction in 
the aorta was abolished at a lower concentration than that used to 
abolish serotonin-induced contraction (Watts et al., 2009).
It is worth noting that vena cava tissues were more sensitive 
to TG II inhibition by cystamine than aortic tissues (Figure 5E). 
There are several ways that TG II could be acting in these two tis-
sues to explain this difference. It may be that protein amidation 
is more important to contraction in the vena cava than in the 
aorta. This is supported by Western analysis showing that a blot 
probed with an anti-NE-BSA antibody (Figure 3A) showed much 
darker staining of vena cava protein bands of the same molecular 
weight than aorta, even when corrected for β-actin (Figure 3B). 
It is also possible that a larger percentage of the adrenergic recep-
tors couple to G
h
 in the vena cava than in the aorta, and this in 
turn results in the greater sensitivity observed. Another explana-
tion is that the difference in banding patterns seen in aorta and 
vena cava homogenates probed with an antibody against NE could 
mean that TG II is regulating different proteins in the two tis-
sues. Finally, though Western analysis showed that aorta and vena 
cava homogenates had the same amount of TG II present when 
equal amounts of protein from these two tissues were analyzed 
(Figure 5F), this does not take into account that TG II was found 
primarily in the smooth muscle cell layer of these tissues. Because 
aorta tissues contain many layers smooth muscle cells while the 
vena cava only contains a single smooth muscle cell layer, homoge-
nates from the aorta would contain more protein from smooth 
muscle cells than from other vascular cell types, while vena cava 
homogenates would contain more protein from other vascular 
cell types than from smooth muscle cells. This could indicate that 
vena cava vascular smooth muscle cells contain more TG II than 
aorta smooth muscle cells.
liMitations
There are a number of limitations that should be recognized in 
this study. First, the aorta and vena cava are large conduit vessels. 
As such, it is not possible to directly relate how this process may 
influence total peripheral resistance, which is largely controlled 
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α-actin, which would explain why we saw α-actin and NE  colocalize 
(Figure 3C). Another issue is the apparent irreversibility of protein 
amidation carried out by TG II. This leads to the question of how 
protein amidation to NE is regulated. It may be that this modifica-
tion is a terminal event for a protein.
In summary, this work is the first to show NE being used as a 
substrate by TG II to modify proteins. These studies suggest that 
protein amidation by NE occurs naturally, and is a biologically 
relevant process that is important for vascular contraction on both 
sides of the vasculature.
by smaller resistance arteries. A second limitation is in the use of 
 cultured cells in this study, although this was mostly avoided by 
carrying out all experiments done in cultured cells in freshly dis-
sociated smooth muscle cells as well. The study also focused on 
α-actin as a candidate for amidation. This was despite only a limited 
detection of protein bands at a molecular weight (around 42 kDa) 
of actins in our blot probed with an antibody raised against NE 
(Figure 3A). Identification of the proteins that are amidated by 
NE will lead to candidates that may be more likely substrates than 
actin for this event. These proteins may physically interact with 
